Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naive cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study

被引：0
|
作者：
Giocanti-Auregan, Audrey [1 ]
Yang, Chang-Hao [2 ]
Donati, Simone [3 ]
Allmeier, Helmut [4 ]
Machewitz, Tobias [5 ]
Rittenhouse, Kay D. [6 ]
Hoerauf, Hans [7 ]
机构：
[1] Sorbonne Paris Nord Univ, Hop Avicenne, Bobigny, France
[2] Natl Taiwan Univ Hosp, Dept Ophthalmol & Coll Med, Taipei, Taiwan
[3] Univ Insubria, Dept Med & Surg, Varese, Italy
[4] Bayer Consumer Care AG, Basel, Switzerland
[5] Bayer AG, Berlin, Germany
[6] Bayer US LLC, Whippany, NJ USA
[7] Univ Med Gottingen, Augenklin, Gottingen, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1762
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Real world clinical audit of aflibercept for management of macular edema secondary to central retinal vein occlusion
    Pakzad-Vaezi, Kaivon
    El-Atfy, Mohammed
    Vrizidou, Eleni
    Addison, Peter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [32] The efficacy of intravitreal ranibizumab for the treatment of macular oedema secondary to retinal vein occlusions in a treatment-naive cohort: 6-month outcomes
    Laginaf, Masara
    Lewis, Adam
    Chandran, Manju
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [33] Two-Year Results of the COPERNICUS Study Evaluating Intravitreal Aflibercept Injection (IAI) for Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
    Clark, W. Lloyd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] Incremental Cost-Utility Ratio of Intravitreal Aflibercept Compared with Ranibizumab for the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion
    Cruess, Alan F.
    Jeddi, Mark
    Goeree, Ron
    Blackhouse, Gord
    Eriksson, Marianne
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] Twenty-Four-Month Results of Intravitreal Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion
    Tsagkataki, M.
    Papathomas, T.
    Lythgoe, D.
    Kamal, A.
    SEMINARS IN OPHTHALMOLOGY, 2015, 30 (5-6) : 352 - 359
  • [36] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    T D Papakostas
    L Lim
    T van Zyl
    J B Miller
    B S Modjtahedi
    C M Andreoli
    D Wu
    L H Young
    I K Kim
    D G Vavvas
    D D Esmaili
    D Husain
    D Eliott
    L A Kim
    Eye, 2016, 30 : 79 - 84
  • [37] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    Papakostas, T. D.
    Lim, L.
    van Zyl, T.
    Miller, J. B.
    Modjtahedi, B. S.
    Andreoli, C. M.
    Wu, D.
    Young, L. H.
    Kim, I. K.
    Vavvas, D. G.
    Esmaili, D. D.
    Husain, D.
    Eliott, D.
    Kim, L. A.
    EYE, 2016, 30 (01) : 79 - 84
  • [38] Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial
    Hykin, Philip
    Prevost, A. Toby
    Vasconcelos, Joana C.
    Murphy, Caroline
    Kelly, Joanna
    Ramu, Jayashree
    Hounsome, Barry
    Yang, Yit
    Harding, Simon P.
    Lotery, Andrew
    Chakravarthy, Usha
    Sivaprasad, Sobha
    Eleftheriadis, Haralabos
    Briggs, Michael
    Williams, Michael
    Abugreen, Salwa
    Ghanchi, Faruque
    Narendran, Nirodhini
    Hughes, Edward
    Ross, Adam
    Gupta, Nitin
    Turner, Stephen
    Osoba, Yinka
    Patel, Jignesh
    Pagliarini, Sergio
    Lip, Peck-Lin
    Patel, Nishal
    Jafree, Afsar
    Menon, Geeta
    Patra, Sudeshna
    Burton, Ben
    Taylor, Simon
    Mackenzie, Sarah
    Gale, Richard
    Vadivelu, Komala
    McKibbin, Martin
    George, Sheena
    Almeida, Goncalo
    Sen, Piyali
    Patrao, Namritha
    Menon, Deepthy
    Nicholson, Luke
    D'Souza, Yvonne
    Talks, James
    Sundaram, Venki
    Banerjee, Sanjiv
    Habib, Maged
    Ram, Raghu
    Brand, Christopher
    Newman, Douglas
    JAMA OPHTHALMOLOGY, 2019, 137 (11) : 1256 - 1264
  • [39] Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
    A J Lotery
    S Regnier
    Eye, 2015, 29 : 380 - 387
  • [40] Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
    D Călugăru
    M Călugăru
    Eye, 2015, 29 : 1113 - 1113
12345